Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abdulbaset Mazarzaei"'
Publikováno v:
Iranian Journal of Immunology, Vol 20, Iss 1, Pp 114-128 (2023)
Background: An issue that hinders researchers’ access to Natural Killer (NK) cells is their low proportion in peripheral blood leukocytes. This issue is currently addressed by methods involving a series of differentiation and expansions that are ti
Externí odkaz:
https://doaj.org/article/c41c5fa6b6244bd68eb8f3d7e3a4f5aa
Autor:
Maryam Bahmanyar, Mohammad Kazem Vakil, Ghaidaa Raheem Lateef Al-Awsi, Seyed Amin Kouhpayeh, Yaser Mansoori, Behnam Mansoori, Ali Moravej, Abdulbaset Mazarzaei, Abdolmajid Ghasemian
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Owing to non-responsiveness of a high number of patients to the common melanoma therapies, seeking novel approaches seem as an unmet requirement. Chimeric antigen receptor (CAR) T cells were initially employed against recurrent or refractory
Externí odkaz:
https://doaj.org/article/5d4aaae2b15c4733981b2b7293521af3
Autor:
Elham Zarenezhad, Manal Hadi Ghaffoori Kanaan, Sura Saad Abdollah, Mohammad Kazem Vakil, Mahrokh Marzi, Abdulbaset Mazarzaei, Abdolmajid Ghasemian
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1245 (2023)
Owing to drawbacks in the current common cancer therapies including surgery, chemotherapy and radiotherapy, the development of more reliable, low toxic, cost-effective and specific approaches such as immunotherapy is crucial. Breast cancer is among t
Externí odkaz:
https://doaj.org/article/7bebcb0bee9e4a22ba8b2ff6355f1063
Autor:
Samah Ahmed Kadhum, Abdulbaset Mazarzaei, Mun’im R. Ali, Yaqdhan Alnomani, Morvarid Shafiei, Hiba Riyadh Al-abodi, Yasemin Khudiar Alghanimi, Nagham M. Al-gburi
Publikováno v:
Reviews in Medical Microbiology. 30:223-227
Autor:
Seyede Amene Mirforughi, Abdolmajid Ghasemian, Hassan Rajabi Vardanjani, Mahtab Vafaei, Abdulbaset Mazarzaei, Nada A.S. Alwan
Publikováno v:
Journal of Cellular Physiology. 234:14812-14817
Human immunodeficiency virus (HIV) is one of the critical infectious agents with thousands of newly infected people worldwide. High mutational capability and rapid diversification, inhibition of humoral and cellular immune responses, and thus inabili